Meprozine

Meprozine Brand names, Meprozine Analogs

Meprozine Brand Names Mixture

No information avaliable

Meprozine Chemical_Formula

C₂₀H₂₃NS

Meprozine RX_link

No information avaliable

Meprozine fda sheet

Meprozine msds (material safety sheet)

Meprozine Synthesis Reference

No information avaliable

Meprozine Molecular Weight

309.469 g/mol

Meprozine Melting Point

< 25 ^oC

Meprozine H₂O Solubility

Soluble as HCl salt

Meprozine State

Liquid

Meprozine LogP

5.7

Meprozine Dosage Forms

Tablets (oral, 1 mg)

Meprozine Indication

Used for the symptomatic treatment of parkinsonism.

Meprozine Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprozine Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprozine side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprozine Patient Information

Meprozine Organisms Affected

Humans and other mammals